Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New AntibacterialsClostridium difficile infection: a review of current and emerging therapiesRecent advances in the understanding of antibiotic resistance in Clostridium difficile infectionGastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infectionClostridium difficile Infection in Special High-Risk PopulationsEpidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative ReviewRole of cephalosporins in the era of Clostridium difficile infectionOutpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklistsRisk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort studyClostridium difficile infection seasonality: patterns across hemispheres and continents - a systematic reviewClostridium difficile: improving the prevention paradigm in healthcare settings.Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.Binaphthyl-1,2,3-triazole peptidomimetics with activity against Clostridium difficile and other pathogenic bacteria.Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.Recurrent Clostridium difficile infection: From colonization to cure.Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit.Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomesReducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback.Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease SeverityAntibiotics as deep modulators of gut microbiota: between good and evil.Hospitalization Type and Subsequent Severe SepsisLoss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With MetronidazoleMultimorbidity in elderly hospitalised patients and risk of Clostridium difficile infection: a retrospective study with the Cumulative Illness Rating Scale (CIRS).Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programsAssessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings.Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaksEpidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel DiseasePilin Vaccination Stimulates Weak Antibody Responses and Provides No Protection in a C57Bl/6 Murine Model of Acute Clostridium difficile InfectionEffects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia.Treatment for Positive Urine Cultures in Hospitalized Adults: A Survey of Prevalence and Risk Factors in 3 Medical Centers.Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.Safety issues and drug-drug interactions with commonly used quinolones.Management of diverticular disease.Dentists, antibiotics and Clostridium difficile-associated disease.Measuring the impact of antimicrobial stewardship programs.Second generation cephalosporin antibiotic prophylaxis and Clostridium difficile infection in hip and knee arthroplasty.
P2860
Q26739860-28716E23-5E13-403C-9ED0-73AC887B3CF5Q26749531-8A016769-2E02-442C-8E48-9C8B99AA4650Q26750157-63055B8D-EBAE-49BD-8C71-5D011C33DAA6Q26767079-4D878446-C0B2-4946-9397-D6901464B5C9Q26776155-72F62497-BFC0-469C-AD71-A130A5E96F17Q28069414-014AB912-C753-4FCD-8CCE-9212FD94FE91Q28073805-3CBD0C27-DF2A-4736-99D4-409A9CFFF795Q28078261-68CDF7F6-09F8-4C50-ACB6-EFA9E1DCCBE4Q28088622-8F3FF7AD-7813-4AE8-9F20-932FA99C4ED7Q33767958-0BB8B33E-1193-49A7-B591-90A4A0930DBDQ34089890-D4AD3003-C420-4BF8-965D-378CCCCC0C5EQ35182396-1C475009-57F9-429D-8FBC-F1BD70944C2AQ35222472-A4F75DE6-20B1-4327-AB89-87BCEB64814AQ35450849-D4FFC7C5-1336-4D77-90AF-A651DD15A3A3Q35611260-1779E563-0092-43AF-822C-8D802717D8DFQ35676675-45B703D4-F4D2-4FCE-A23C-5C4FAD4F5A4BQ35822541-CA795DF2-F3D3-483D-A3A3-D25033E8DA24Q35860076-43CB9AC0-0A11-47C7-919A-967FDFADCB67Q35888706-8829DC3B-A797-456F-827A-185AC2932D4EQ35908360-A867A323-B997-414E-BC84-8FCC9A469011Q36083653-334C5342-4E4A-4A9F-A26A-19ED6CF418B5Q36100345-437781A5-E916-4E9D-8E7A-933B14E96062Q36105508-DEDBFC09-792B-45B7-982A-4AC9FFD7B1C1Q36128633-B5BB4B78-0DA1-49FF-B61A-212802F702D4Q36208584-A42E4AF5-3824-414E-9A90-4D63276E2877Q36258760-99776685-D146-4C15-8637-A034F0E80699Q36275773-74EF3B46-6683-412C-85C5-A414B175BAACQ36391688-B96E6970-1DA9-4261-A6F2-A2610B448A6BQ36970016-FA7D01E5-F497-413E-B119-0721A0C328C1Q37014160-30A03B61-0D89-4138-B606-B4A1B91DE054Q37052336-1828F8CE-2003-45F8-99E4-BFAC73BD871CQ37338130-21E9D4B4-D292-4BDA-8420-EE6578D7E181Q37385413-181A080C-8142-410F-AD72-19015604A63EQ37481607-6FE961B5-936C-427C-A052-089702DD606EQ37581870-F641832D-E386-47E5-BC7B-6687760F4C4FQ38271318-FAF8F675-E7AE-4EB8-8F4D-5B928B4FC506Q38546428-61941BC8-58A2-4741-8C9F-E4BB8F1ACE5FQ38592679-15D8868E-9C69-4116-A350-D6672FC30316Q38807973-A03A9610-B200-485A-AF31-0E2A0B22D271Q38809707-CEA41AEB-0D62-4E26-9872-08419E1C7245
P2860
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@ast
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@en
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@nl
type
label
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@ast
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@en
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@nl
prefLabel
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@ast
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@en
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@nl
P31
P921
P3181
P356
P1476
Antibiotics and hospital-acqui ...... matic review and meta-analysis
@en
P2093
Thomas V Riley
P304
P3181
P356
10.1093/JAC/DKT477
P407
P577
2014-04-01T00:00:00Z